Immunology research bonds

What would change?

Authorizes $8.4 billion in general-obligation bonds for immunology and immunotherapy research. The research allocation is divided between one qualifying nonprofit institute and competitive grants to eligible council-represented universities and nonprofits. Discovery, treatment access, and financial returns are uncertain.

Where money goes.
Who controls it.

Public funding and campaign donations are separate. Where this measure creates no new funding pool, the table explains the budget authority or restriction instead.

Flexibility, exceptions, and possible diversion

The institute and grant recipients choose projects within broad research purposes. Authorized overhead, issuance costs, and debt-related transactions mean all bond dollars do not buy direct laboratory work. §130363 exempts the institute from public-agency status, including ordinary public-records and open-meeting rules; the council has modified conflict rules and recusal requirements. The act allows two-thirds legislative amendments for its purposes but restricts changing eligible funding allocations. These are transparency limits and express exceptions, not proof of improper spending.

Oversight and accountability limits

Annual reports and independent financial audits cover the institute and council; council audits also include a random 10% of grantees. The Controller reviews audits and issues public reports. A citizens’ oversight committee meets publicly. Discovery-revenue and treatment-discount provisions have conditions; they do not guarantee cures or repayment of the bonds.

No actual expenditure inconsistent with this proposed law has been established here. Authorized administration, exceptions, or legal-defense costs are disclosed separately from headline benefits. Future appropriations, transfers, contracts, waivers, and audit findings must be checked before calling an expenditure misuse.

Who may benefit.
Who may bear costs.

These are Ballot Lens interpretations of the law’s mechanisms and fiscal analysis. Actual effects depend on implementation and behavior.

Support and opposition.

Supporters listed in the official guide: Michael J. Fox Foundation; Alzheimer’s Los Angeles; Kidney Cancer Assoc; American Nurses Assoc\CA.

Opponents listed in the official guide: Robert M Kaplan Ph.D..

“None submitted” describes that guide field. It does not establish the absence of supporters, opponents, campaigns, or contributions. An endorsement, argument signature, and donation are distinct evidence.

Complete submitted arguments and rebuttals

The official submissions appear below, as the authors’ opinions. Their claims are not verified by the state. An individual’s affiliation does not by itself establish an organizational endorsement.

Check competing claims.

These checks explain comparisons and qualifications; they are not a truth score for every campaign assertion.

Messages and emotional appeals.

Messages are attributed to the linked campaign or official submission. Emotional appeals are Ballot Lens interpretations of persuasion techniques, not findings about motives.

Who funds the campaigns?

Power Search contribution records through Oct 9, 2026 · 26 reconciled records · retrieved Oct 11, 2026. These are receipts, not expenditures or public-program allocations.

Supporting and opposing committees: who they are

A recipient committee raises or receives funds for political activity and files public reports. A primarily formed ballot-measure committee campaigns for or against a particular measure; other committees can have wider purposes. Names and reported positions do not establish a complete membership list or every named group’s endorsement.

Power Search measure-associated receipts and Quick Guide adjusted primarily formed committee totals use different coverage. A zero in one source is not proof of no spending. Multi-measure committee totals must not be added across propositions.

Who proposed it?
How does it connect?

The Attorney General identifies Gary K. Michelson as proponent. This initiative statute qualified through petition signatures.

Qualified for California’s November 3, 2026 ballot; not yet approved by voters. Proponents, legislative authors, endorsers, argument signatories, and committee officers have different roles.

Related measures

Compare the General Fund debt obligation with Proposition 1’s bonds and Proposition 37’s revenue bonds. Their repayment mechanisms differ.

Ready for your review.

All assessments remain research drafts awaiting human editorial review. The following measure-specific items need attention:

• Verify which institute meets the selection criteria and any statutory fallback selection before identifying the beneficiary by name.
• Review conflict exceptions, grant overhead, and discovery-revenue contracts.

Across all measures, original finance filings and amendments, expenditures, indirect funding, litigation, and actual spending compliance remain outside the verified dataset. Predictions are conditional. This assessment does not certify future conduct.

• Proposition 38 · Initiative 25-0026A1 · Official proposed law ↗Constitutional and statutory mechanisms
• Nonpartisan LAO analysis ↗Fiscal estimates and uncertainty
• Submitted arguments and rebuttals ↗Attributed opinions
• Official Quick Guide ↗Endorsements, campaign links, and adjusted finance context